Tag Archive for: Optimum
Weekly roundup: A conference crawl from London to Prague to Copenhagen
With the Anglonordic Life Science Conference last week, BioEquity next week, ASGCT Annual meeting and LSX Nordic Congress around the corner, it is a good time to practice your pitching. Funds are open and now is the time to foster those new and old connections. Read on to discover what has happened this week and […]
Weekly roundup: Financial milestones to scientific breakthroughs, leadership moves and major industry events
Novo Holdings announces 2025 Annual Results Novo Holdings announced its financial results for 2025. Despite a challenging global environment, Novo Holdings has made significant progress on its Strategy 2030 during 2025 and delivered on its priorities. The Novo Holdings Investment Portfolio continued to perform well on both an absolute and relative basis, with a return […]
Weekly roundup: Approvals, patents and pricing: healthcare regulation heats up
PDUFA action date for Hansa Biopharma’s imlifidase BLA set for December 19, 2026 Hansa Biopharma announced that the Food and Drug Administration (FDA) has notified the company that the previously accepted Biologics License Application (BLA) for imlifidase has been assigned a Prescription Drug User Fee Act (PDUFA) action date of December 19, 2026. 📺Optimum TV […]
Register today: Anglonordic Life Science Conference 2026
As one of the organisers, Optimum is proud to partner with Anglonordic year on year to curate an awesome agenda for this fantastic event. Exclusively for European investors and R&D companies…
